Status:
COMPLETED
Patients Preference for Oral or i.v. Therapy
Lead Sponsor:
Odense University Hospital
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Until recently, bolus 5-flourouracil (FU) + folinic acid (FA) has been considered the standard chemotherapy for patients with colorectal cancer. Several studies have shown that Capecitabine is as effe...
Eligibility Criteria
Inclusion
- Indication for treatment with a FU-regime
- WHO Performance Status 0-1
- Life expectancy \> 3 months
- Adequate haematological, renal and hepatic functions
- Adequate contraceptives
- Written informed consent
Exclusion
- Known CNS-metastases
- Prior treatment with chemotherapy
- Pregnant or breast feeding women
- Current infection, unresolved bowel obstruction or subobstruction, uncontrolled Crohn's disease or ulcerative colitis
- other serious illness or medical conditions
Key Trial Info
Start Date :
December 1 2002
Trial Type :
INTERVENTIONAL
End Date :
April 1 2004
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00212589
Start Date
December 1 2002
End Date
April 1 2004
Last Update
September 21 2005
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Oncology, Esbjerg Hospital
Esbjerg, Denmark, 6700
2
Department of Oncology, Odense University Hospital
Odense, Denmark, 5000
3
Department of Oncology, Sonderborg Hospital
Sønderborg, Denmark, 6400
4
Department of Oncology, Vejle Hospital
Vejle, Denmark, 7100